RODOS BIOTARGET
Rodos BioTarget (RBT) is a biopharmaceutical company developing a targeted drug delivery platform. RBT’s patented TargoSphere® technology enables carrying a broad range of active agents selectively into the center of the immune response - i.e., directly into antigen-presenting cells. RBT currently applies its TargoSphere® technology successfully in various models of infectious diseases caused by viruses like HCV/ Hepatitis C and HIV/ AIDS and by bacteria like in Tuberculosis, Legionellosis, and MRSA. Yet, any disorder that goes along with either overshooting or insufficient immunity caused by antigen-presenting cells - like chronic inflammations, cancers, allergies, and autoimmune diseases - may be addressed by RBT’s TargoSphere® technology.
RODOS BIOTARGET
Industry:
Biopharma Biotechnology Pharmaceutical
Founded:
2008-01-01
Address:
Hanover, Niedersachsen, Germany
Country:
Germany
Website Url:
http://www.biotargeting.eu
Total Employee:
1+
Status:
Active
Contact:
49 173 317 0879
Email Addresses:
[email protected]
Total Funding:
3.6 M USD
Technology used in webpage:
SPF
Similar Organizations
Celator Pharmaceuticals
Celator Pharmaceuticals is a biopharmaceutical company developing therapies to treat cancer, using the drug ratio technology platform.
Current Employees Featured
Founder
Investors List
Aescuvest
Aescuvest investment in Equity Crowdfunding - Rodos BioTarget
Christopher Isak
Christopher Isak investment in Seed Round - Rodos BioTarget
ERP Startfonds
ERP Startfonds investment in Venture Round - Rodos BioTarget
High-Tech Grunderfonds
High-Tech Grunderfonds investment in Venture Round - Rodos BioTarget
Enjoyventure Management
Enjoyventure Management investment in Venture Round - Rodos BioTarget
Business Angels Agentur Ruhr
Business Angels Agentur Ruhr investment in Venture Round - Rodos BioTarget
High-Tech Grunderfonds
High-Tech Grunderfonds investment in Seed Round - Rodos BioTarget
Official Site Inspections
http://www.biotargeting.eu
- Host name: 104.247.81.53
- IP address: 104.247.81.53
- Location: Canada
- Latitude: 43.6319
- Longitude: -79.3716
- Timezone: America/Toronto
More informations about "Rodos BioTarget"
Rodos BioTarget - Crunchbase Company Profile & Funding
Organization. Rodos BioTarget . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. ... Contact Email [email protected]; …See details»
Rodos BioTarget - Overview, News & Similar companies - ZoomInfo
View Rodos BioTarget (www.biotargeting.eu) location in Lower Saxony, Germany , revenue, industry and description. Find related and similar companies as well as employees by title and …See details»
Rodos BioTarget GmbH Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Rodos BioTarget GmbH of Hannover, Niedersachsen. Get the latest business insights from Dun & …See details»
Rodos BioTarget Receives Growth Financing of EUR 2.6 m
For additional information, please visit www.biotargeting.eu. Contact: Rodos BioTarget GmbH Dr. M. Furch (CEO) + 49 (0)176 3921 3096. Dr. R. Gieseler-von der Crone (CSO) +49 (0)176 …See details»
Rodos BioTarget Company Profile 2025: Valuation, Funding
Information on valuation, funding, cap tables, investors, and executives for Rodos BioTarget. Use the PitchBook Platform to explore the full profile.See details»
Rodos BioTarget GmbH - Drug pipelines, Patents, Clinical trials
Www.biotargeting.eu. Private Company | 2008 | Germany | < 10 | www.biotargeting.eu. Last update 07 Mar 2025. Overview. Pipeline. Deal. Translational Medicine. Profit. Grant & …See details»
Rodos Biotarget GmbH Overview | SignalHire Company Profile
Organization Website: biotargeting.eu : Social Links: Phone Number: 49-511-7273-8835: Rodos Biotarget GmbH industries Pharma: Headquarters Location: Medical Park Hannover, Feodor …See details»
WE COMBINE SCIENTIFIC AND BUSINESS COMPETENCES - Biotarget
The role of the immune system and the significance of different types of immune responses are the subject of increasingly intensive research efforts. In recent years we witnessed how …See details»
Rodos BioTarget (Rodos BioTarget GmbH) - Startbase
Official Website: biotargeting.eu; On Social Media: Juristische Person: Rodos BioTarget GmbH Bundesland: Niedersachsen Übersicht Unternehmen Finanzierung Produkt Team Nachrichten …See details»
Rodos Biotarget Company Profile - Office Locations, Competitors …
Rodos Biotarget has 5 employees across 2 locations and $3.4 m in total funding,. See insights on Rodos Biotarget including office locations, competitors, revenue, financials, executives, …See details»
Rodos BioTarget GmbH (Rodos BioTarget GmbH) - 药物管线_专 …
了解Rodos BioTarget GmbH (Rodos BioTarget GmbH)公司的药物管线，治疗领域，技术平台，以及它的5篇文献，药物:TargoBiotics，RBT-08。See details»
Frisches Kapital für Nanomedizinentwicklung gegen chronisch ...
Www.biotargeting.eu. Über das ProFIT-Programm / Investitionsbank des Landes Brandenburg (ILB) Das Förderprogramm ProFIT unterstützt Unternehmen und Forschungseinrichtungen im …See details»
Rodos BioTarget erhält Startfinanzierung vom High-Tech …
Zusätzliche Information entnehmen Sie unserer Internetseite: www.biotargeting.eu. Kontakt: Rodos BioTarget GmbH Medical Park Hannover Feodor-Lynen-Str. 23 30625 Hannover …See details»
Research programme: carbohydrate-targeted nanocarrier - Rodos …
If your organization has a subscription, there are several access options, even while working remotely: Working within your organization’s network Login with username/password or try to …See details»
Biotargeted nanomedicines for cancer: six tenets before you begin
The Biotargeting Working Group, consisting of more than 50 pharmaceutical scientists, engineers, biologists and clinicians, has been formed as part of the National Cancer Institute’s Alliance for …See details»
Rodos BioTarget (Rodos BioTarget GmbH) - Startbase
Date News; 18.09.2018 10:06: Rodos Biotarget erhält öffentliche Fördermittel für Kampf gegen bakterielle Infektionen Hochrangiges Forschungskonsortium wird mit 2,8 Mio. Euro über drei …See details»
ww1.biotargeting.eu
Ww1.biotargeting.euSee details»
Fighting bioterrorism – Europe works on master plan
Bioterrorism is the intentional release of harmful biological agents such as bacteria, viruses, or toxins. To protect citizens and national infrastructure, the race is on to improve Europe’s …See details»
Goals and activities | Biotargeting
The Principal goals of the Biotargeting network cover 3 directive axes that have diverse activities: 1/ Pharmacotargeting of diseases. 1a. Study of the mechanisms underlying the pathobiology …See details»
Future of European defence - European Commission
The ReArm Europe Plan/ Readiness 2030 will boost defence funding by giving EU countries more financial flexibility. It will achieve this by: activating the national escape clause of the Stability …See details»